Overview
Juvenile nephronophthisis (JN) is a genetic disorder characterized by progressive tubulointerstitial nephropathy leading to chronic kidney disease, often accompanied by extrarenal manifestations such as hepatic fibrosis, retinal abnormalities, and skeletal anomalies 134.Diagnosis
Clinical Presentation: Chronic kidney disease, hepatosplenomegaly, retinal abnormalities, and skeletal deformities 14.
Renal Biopsy: Essential for confirming tubulointerstitial nephropathy characteristic of JN 2.
Genetic Testing: Considered for familial cases to identify specific genetic mutations 13.
Imaging: Ultrasound and MRI may reveal structural renal abnormalities and hepatic changes 13.
Ophthalmic Evaluation: Essential for detecting retinal hypoplasia or degeneration 4.
Liver Function Tests: Elevated markers may indicate hepatic involvement 13.Management
Supportive Care: Fluid management, electrolyte balance, and blood pressure control 1.
Dialysis/Transplantation: Indicated for end-stage renal disease 1.
Monitoring Comorbidities: Regular assessment for associated conditions like epilepsy and gout 2.
Genetic Counseling: Recommended for families with a history of JN or medullary cystic disease 2.
Specific Treatments: No specific pharmacological treatments mentioned; management focuses on symptom control and complications 1234.Special Populations
Pediatrics: Early recognition and multidisciplinary management crucial due to rapid progression 14.
Comorbidities: Consider associations with gout, epilepsy, and endocrine disorders in genetic counseling and monitoring 2.Key Recommendations
Renal Biopsy for Diagnosis and Genetic Counseling: Perform renal biopsy in suspected cases and consider genetic counseling for familial patterns, even in asymptomatic relatives with normal renal function 2 (Evidence: Moderate).
Comprehensive Multidisciplinary Approach: Address renal, hepatic, ocular, and skeletal manifestations through a multidisciplinary team 134 (Evidence: Expert opinion).
Monitor for Associated Conditions: Regularly screen for comorbidities such as gout and epilepsy in patients with JN 2 (Evidence: Moderate).References
1 Bianchi C, Barera G, Picciotti M, Barbiano di Belgioioso G, Bellini F. Juvenile nephronophthisis associated with new skeletal abnormalities, tapetoretinal degeneration and liver fibrosis. Helvetica paediatrica acta 1989. link
2 Burke JR, Inglis JA, Craswell PW, Mitchell KR, Emmerson BT. Juvenile nephronophthisis and medullary cystic disease--the same disease (report of a large family with medullary cystic disease associated with gout and epilepsy). Clinical nephrology 1982. link
3 Dieterich E, Straub E. Familial juvenile nephronophthisis with hepatic fibrosis and neurocutaneous dysplasia. Helvetica paediatrica acta 1980. link
4 Delaney V, Mullaney J, Bourke E. Juvenile nephronophthisis, congenital hepatic fibrosis and retinal hypoplasia in twins. The Quarterly journal of medicine 1978. link